Your browser doesn't support javascript.
loading
Regulatory fine-tuning of mcr-1 increases bacterial fitness and stabilises antibiotic resistance in agricultural settings.
Ogunlana, Lois; Kaur, Divjot; Shaw, Liam P; Jangir, Pramod; Walsh, Timothy; Uphoff, Stephan; MacLean, R C.
  • Ogunlana L; Department of Biology, University of Oxford, 11a Mansfield Road, Oxford, OX1 3SZ, UK.
  • Kaur D; Department of Biology, University of Oxford, 11a Mansfield Road, Oxford, OX1 3SZ, UK.
  • Shaw LP; Department of Biology, University of Oxford, 11a Mansfield Road, Oxford, OX1 3SZ, UK.
  • Jangir P; Department of Biosciences, Durham University, Stockton Road, Durham, DH1 3LE, UK.
  • Walsh T; Department of Biology, University of Oxford, 11a Mansfield Road, Oxford, OX1 3SZ, UK.
  • Uphoff S; Department of Biology, University of Oxford, 11a Mansfield Road, Oxford, OX1 3SZ, UK.
  • MacLean RC; Ineos Oxford Institute for Antimicrobial Research, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK.
ISME J ; 17(11): 2058-2069, 2023 11.
Article en En | MEDLINE | ID: mdl-37723338
ABSTRACT
Antibiotic resistance tends to carry fitness costs, making it difficult to understand how resistance can be maintained in the absence of continual antibiotic exposure. Here we investigate this problem in the context of mcr-1, a globally disseminated gene that confers resistance to colistin, an agricultural antibiotic that is used as a last resort for the treatment of multi-drug resistant infections. Here we show that regulatory evolution has fine-tuned the expression of mcr-1, allowing E. coli to reduce the fitness cost of mcr-1 while simultaneously increasing colistin resistance. Conjugative plasmids have transferred low-cost/high-resistance mcr-1 alleles across an incredible diversity of E. coli strains, further stabilising mcr-1 at the species level. Regulatory mutations were associated with increased mcr-1 stability in pig farms following a ban on the use of colistin as a growth promoter that decreased colistin consumption by 90%. Our study shows how regulatory evolution and plasmid transfer can combine to stabilise resistance and limit the impact of reducing antibiotic consumption.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colistina / Proteínas de Escherichia coli Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colistina / Proteínas de Escherichia coli Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article